Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Dec 8, 2017
Document Date
Dec 6, 2017
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
Bermingham Nessan